Richard A. Larson to Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
This is a "connection" page, showing publications Richard A. Larson has written about Precursor B-Cell Lymphoblastic Leukemia-Lymphoma.
Connection Strength
1.311
-
Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/Lymphoma. Curr Hematol Malig Rep. 2023 Dec; 18(6):217-225.
Score: 0.895
-
Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia. Blood Adv. 2018 07 10; 2(13):1522-1531.
Score: 0.158
-
Blinatumomab treatment of older adults with relapsed/refractory B-precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies. Cancer. 2016 07 15; 122(14):2178-85.
Score: 0.136
-
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study. Lancet Oncol. 2015 Jan; 16(1):57-66.
Score: 0.123